Organiser
Conrming its expertise in active ingredients for hair, Seppic completes its hair care offer with an ingredient designed to make hair naturally more beautiful: XYLISHINE™C.
Inspired by the "skinication" trend (taking care of its scalp like its skin), Seppic has created XYLISHINE™ C, an active ingredient acting holistically on scalp and hair cuticle repair. Thanks to XYLISHINE™ C, hair becomes visibly more beautiful with increased shine, better curl denition and volume control.
XYLISHINE™ C is a natural active ingredient derived from a patented complex of sugar derivatives recognized for their moisturizing action in skin care, associated with a bio-inspired algae harvested in France (Brittany), Pelvetia canaliculata. It is well-known for its exceptional resistance to dehydration.
Seppic's Research & Innovation teams have demonstrated that XYLISHINE™ C helps restore the scalp by increasing its ceramide content by 27%* and strengthening its skin barrier by 42%*. It also helps repair the surface appearance of damaged cuticles by 82%**.
Thanks to this mode of action, XYLISHINE™ C increases the shine of all hair types, curly or straight (+7%***), curls are better dened (+16%***), and hair is softer to the touch (+7%***).
It is also ecient in different climates (tested ex vivo in standard and extreme temperature and humidity conditions) for visible anti-frizz action and hair volume control.
Compliant with Chinese IECIC and IECSC regulations, XYLISHINE™ C is also COSMOS and Natrue approved, with a naturality rate of 99.7% according to ISO 16128.
Audrey Bonnard, Active Product Manager at Seppic, said: "XYLISHINE™ C meets a strong expectation in the haircare market for ingredients with global ecacy, both on the scalp and the hair ber. Tests carried out on different hair types and in different climates make it particularly interesting for beautifying all hair types anywhere in the world."
*In vivo test on 20 men and women volunteers applying a shampoo containing 3% Xylishine™ C or a placebo shampoo for 28 days. **Ex vivo test applying a 3% Xylishine™ C solution to healthy and damaged hair. ***In vivo test on 2 groups of volunteers with curly or straight hair applying leave-on or shampoo containing 3% Xylishine™ C or placebo
Seppic in brief
A subsidiary of Air Liquide Healthcare, Seppic designs, produces and distributes for 80 years a wide range of specialty ingredients for cosmetic, nutraceutical, pharmaceutical, veterinary and industrial products. Seppic employs close to 900 people worldwide, including 110 employees dedicated to innovation who develop effective ingredients with unique characteristics. Present in 100 countries through its subsidiaries and its network of distributors, Seppic aims to help everyone live well, and in good health in a healthy environment. www.seppic.com
Healthcare activities at Air Liquide
Air Liquide Healthcare is a world leader in medical gases, home healthcare services and specialty ingredients. Our 16,500 employees support 2 million chronic patients and provide medical gases and related services to 20,000 hospitals and new care facilities, as well as 140,000 healthcare professionals. Committed to working alongside professionals and health institutions, our patient-centered approach is based on the principles of Value-based Healthcare, which aims to improve the benets experienced by patients, at the best cost to society, thus contributing to a more ecient and virtuous system.
Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientic territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining nancial and extra-nancial dimensions. Positioned on new markets, the Group benets from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes